Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Perpetua Medical AB (OTCPK:PPTMF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Perpetua Medical AB's Enterprise Value for the quarter that ended in Mar. 2026 was $8.18 Mil.
Perpetua Medical AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perpetua Medical AB EV-to-EBIT Related Terms
Perpetua Medical AB EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Perpetua Medical AB's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Perpetua Medical AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perpetua Medical AB EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Perpetua Medical AB's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Perpetua Medical AB's EV-to-EBIT falls into.
Perpetua Medical AB's current Enterprise Value is $1.71 Mil.
Perpetua Medical AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perpetua Medical AB (PPTMF) has a EV-to-EBIT of 68.24 as of Jul. 22, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Perpetua Medical AB and its competitors. According to the industry distribution chart, Perpetua Medical AB ranks #415 out of 465 companies in the Medical Devices & Instruments industry, placing it in the top 89.2%.
Is Perpetua Medical AB's EV-to-EBIT too high?
Perpetua Medical AB's current EV-to-EBIT is 68.24. The Medical Devices & Instruments industry median EV-to-EBIT is 18.28. Perpetua Medical AB's value of 68.24 is 273.3% above this industry median. Based on the distribution chart, Perpetua Medical AB ranks #415 out of 465 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Perpetua Medical AB has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Perpetua Medical AB's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Perpetua Medical AB ranks #415 out of 465 companies for EV-to-EBIT. This places Perpetua Medical AB in the lower half of its industry. The industry median EV-to-EBIT is 18.28. Perpetua Medical AB's value of 68.24 is 273.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.28, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Perpetua Medical AB's current EV-to-EBIT of 68.24 is 273.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Perpetua Medical AB and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perpetua Medical AB's current EV-to-EBIT is 68.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perpetua Medical AB stock overvalued right now?
Perpetua Medical AB (PPTMF) has a current EV-to-EBIT of 68.24. The stock's GF Value™ is $1.10, compared to a current price of $1.08 — trading 1.9% below its estimated fair value. The current EV-to-EBIT is 68.24 and 273.3% above the Medical Devices & Instruments industry median of 18.28. Perpetua Medical AB's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Perpetua Medical AB (PPTMF), the current EV-to-EBIT is 68.24 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Perpetua Medical AB (PPTMF) Overvalued in 2026?
Based on GuruFocus' analysis, Perpetua Medical AB stock appears to be undervalued.
The current stock price of $1.08 is trading 1.9% below its estimated GF Value™ of $1.10.
Key valuation signals for PPTMF:
EV-to-EBIT: 68.24
GF Value™: $1.10 vs. price of $1.08 (1.9% below fair value)
Industry Position: 273.3% above the Medical Devices & Instruments median (#415 of 465)
No single metric tells the full story. See the PPTMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Perpetua Medical AB is engaged in healthcare sector. The company develops systems and solutions that plan to optimize and ensure correct and effective treatment with injectable drugs. Its products include WasteLog and Pharmacolog Dashboard.
58GF Score
Get the complete analysis for PPTMF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PPTMF has been successfully added to your 
